EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel variant in the FLCN gene in a Chinese family with Birt–Hogg–Dubé syndrome

He Miao iD, Yulin Zhou, Silun Ge, Yufeng Gu, Le Qu, Wenquan Zhou, Haowei He

Molecular Genetics & Genomic Medicine · 2024

DOI: 10.1002/mgg3.2488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von He Miao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Jinling Hospital, Jinling School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Birt-Hogg-Dube Syndrome, Frameshift Mutation, Proto-Oncogene Proteins, Tumor Suppressor Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to identify disease‐causing variants within a Chinese family affected by Birt–Hogg–Dubé syndrome (BHDS), which arises from an autosomal dominant inheritance pattern attributed to variants in the folliculin ( FLCN ) gene, recognized as a tumor suppressor gene.

Methods

A Chinese proband diagnosed with BHDS due to renal tumors underwent next‐generation sequencing (NGS), revealing a novel variant in the FLCN gene. Sanger sequencing was subsequently performed on blood samples obtained from family members to confirm the presence of this variant.

Results

A novel germline frameshift variant (NM_144997.5:c.977dup) was identified in five individuals among the screened family members, marking the first report of this variant. Additionally, a somatic frameshift variant (NM_144997.5:c.1252del) was detected in the renal tumors of the proband. No variant was detected in unaffected family members.

Conclusions

A novel heterozygous variant was identified in exon 9 of the FLCN gene, which broadens the spectrum of FLCN variants. We recommend that molecular analysis of the FLCN gene be performed in patients with suspected BHDS and their families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Birt-Hogg-Dube SyndromeFrameshift MutationProto-Oncogene ProteinsTumor Suppressor ProteinsAdultFemaleHumansMaleMiddle AgedEast Asian PeopleGerm-Line MutationHeterozygoteKidney NeoplasmsPedigree

Stichwörter der Autor:innen

FLCNBirt–Hogg–Dubégeneticrenal tumorvariant

Substanzen

FLCN protein, humanProto-Oncogene ProteinsTumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Urology, Jinling Hospital, Jinling School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Urology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.

ORCID-Profile: He Miao

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Miao, H., Zhou, Y., Ge, S., Gu, Y., Qu, L., Zhou, W., & He, H. (2024). A novel variant in the FLCN gene in a Chinese family with Birt–Hogg–Dubé syndrome. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2488

Vancouver

Miao H, Zhou Y, Ge S, Gu Y, Qu L, Zhou W, et al. A novel variant in the FLCN gene in a Chinese family with Birt–Hogg–Dubé syndrome. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.2488

BibTeX
@article{Miao2024,
  author = {Miao, He and Zhou, Yulin and Ge, Silun and Gu, Yufeng and Qu, Le and Zhou, Wenquan and He, Haowei},
  title = {A novel variant in the FLCN gene in a Chinese family with Birt–Hogg–Dubé syndrome},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2024},
  doi = {10.1002/mgg3.2488}
}
Kostenlos starten →